Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.85x is 56% above its 4-year average of -11.09x, near the high end of its 4-year range (-69.57x–3.46x).
10.96% below its 12-month average of -4.37x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.85x.
INTEREST COVERAGE RATIO
-4.85x
INTEREST COVERAGE RATIO AVG TTM
-4.37x
INTEREST COVERAGE RATIO AVG 3Y
-10.71x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.96%
CURRENT VS 3Y AVG
+54.73%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-15.48%
vs the sector median at left
Adaptive Biotechnologies Corporation
Market Cap
$4.84B
Interest Coverage Ratio
-4.85x
TTM Avg
-4.37x
3Y Avg
-10.71x
5Y Avg
N/A
Market Cap
$4.81B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.74B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
Market Cap
$4.95B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.96B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.65B
Interest Coverage Ratio
-4.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.49B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
Market Cap
$5.20B
Interest Coverage Ratio
-55.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.84B | -4.85x | -4.37x | -10.71x | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | -30.34x | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.74B | 2.07x | 2.07x | 2.07x | 1.38x |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.95B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.96B | 168.66x | 168.66x | 168.66x | 168.66x |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.65B | -4.22x | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.49B | 5.89x | 3.33x | 3.33x | 4.95x |
| Erasca, Inc. (ERAS)vs › | $5.12B | N/A | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | -55.80x | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 6.97x | 5.98x | 8.44x | 9.07x |
Interest Coverage
-4.8x
Debt/Equity
2.87
Current Ratio
4.79
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.85x |
| 2026-03-31 | -6.65x |
| 2025-12-31 | -4.32x |
| 2025-09-30 | 3.46x |
| 2025-06-30 | -8.49x |
| 2025-03-31 | -10.19x |
| 2024-12-31 | -11.46x |
| 2024-09-30 | -11.10x |
| 2024-06-30 | -17.55x |
| 2024-03-31 | -16.29x |
| 2023-12-31 | -23.59x |
| 2023-09-30 | -13.95x |
| 2023-06-30 | -13.26x |
| 2023-03-31 | -16.20x |
| 2022-12-31 | -10.93x |
| 2022-09-30 | -69.57x |
